Confocal Endomicroscopy for Barrett's Esophagus
CEBE
Confocal Laser Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Associated Neoplasia
1 other identifier
interventional
46
1 country
1
Brief Summary
The purpose of this study is to determine if confocal laser endomicroscopy (CLE) can improve detection of Barrett's esophagus, dysplasia, and early esophageal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 18, 2007
CompletedFirst Posted
Study publicly available on registry
June 19, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedResults Posted
Study results publicly available
August 17, 2011
CompletedJune 22, 2021
June 1, 2021
1.1 years
June 18, 2007
June 21, 2011
June 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Yield for Neoplasia in High Risk Patients(Suspected Neoplasia)
The yield for neoplasia is calculated by the number of biopsies showing neoplasia over the total number of biopsies taken (normal + neoplastic biopsies)
6 weeks
Secondary Outcomes (5)
Mean Number of Biopsies With Neoplasia in High Risk Patients (Suspected Neoplasia)
6 weeks
Mean Number of Biopsies Taken in High Risk Patients (Suspected Neoplasia)
6 weeks
Diagnostic Yield for Neoplasia in Barrett's Surveillance Patients
6 weeks
Mean Number of Biopsies With Neoplasia in Barrett's Surveillance Patients
6 weeks
Mean Number of Biopsies Taken in Barrett's Surveillance Patients
6 weeks
Study Arms (2)
CLE followed by standard EGD
ACTIVE COMPARATORParticipants are randomized to have either confocal laser endomicroscopy (CLE) or standard endoscopy (EGD) first. Then 6 weeks later, they have the other procedure. This arm is for patients randomized to CLE followed by standard EGD
standard EGD followed by CLE
ACTIVE COMPARATORPatients are randomized to either have standard endoscopy (EGD)or confocal laser endomicroscopy (CLE) first. The second procedure is then completed 6 weeks later. This arm is for patients who had standard endoscopy first.
Interventions
Confocal laser endomicroscopy is done by performing standard endoscopy, then using a microscope on the tip of the endoscope to obtain microscopic images of the mucosa. This is done by gently placing the tip of the endoscope on the lining of the esophagus.
Standard upper endoscopy (EGD) is performed using a regular upper endoscope, which is used to look at the lining of the esophagus.
Eligibility Criteria
You may qualify if:
- Barrett's esophagus or suspected Barrett's-associated neoplasia
- Age \> 18
- Able to give informed consent
You may not qualify if:
- Known advanced malignant disease
- Allergy to the fluorescent contrast agent fluorescein sodium
- Coagulopathy or bleeding disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- American Society for Gastrointestinal Endoscopycollaborator
- Pentax, USAcollaborator
Study Sites (1)
Johns Hopkins Hospital
Baltimore, Maryland, 21205, United States
Related Publications (1)
Dunbar KB, Okolo P 3rd, Montgomery E, Canto MI. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest Endosc. 2009 Oct;70(4):645-54. doi: 10.1016/j.gie.2009.02.009. Epub 2009 Jun 25.
PMID: 19559419RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Relatively small study (39 patients) and performed at a tertiary care, referral center, which can reduce generalizability.
Results Point of Contact
- Title
- Dr. Marcia Canto.
- Organization
- Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology
Study Officials
- PRINCIPAL INVESTIGATOR
Marcia I Canto, MD, MHS
Division of Gastroenterology, Johns Hopkins University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2007
First Posted
June 19, 2007
Study Start
April 1, 2007
Primary Completion
May 1, 2008
Study Completion
September 1, 2008
Last Updated
June 22, 2021
Results First Posted
August 17, 2011
Record last verified: 2021-06